Sign up
Log in
12 Health Care Stocks Moving In Wednesday's Intraday Session
Share
Listen to the news

Gainers

  • Aptevo Therapeutics (NASDAQ:APVO) shares rose 114.5% to $6.05 during Wednesday's regular session. The company's market cap stands at $4.0 million.
  • Immuneering (NASDAQ:IMRX) shares increased by 31.68% to $2.4. The company's market cap stands at $86.2 million.
  • Geovax Labs (NASDAQ:GOVX) shares increased by 29.86% to $1.17. The company's market cap stands at $17.7 million.
  • Biodexa Pharmaceuticals (NASDAQ:BDRX) stock moved upwards by 26.83% to $1.01. The company's market cap stands at $2.9 million.
  • Galectin Therapeutics (NASDAQ:GALT) stock moved upwards by 23.01% to $2.94. The company's market cap stands at $186.0 million.
  • Creative Medical Tech (NASDAQ:CELZ) shares moved upwards by 20.53% to $2.7. The company's market cap stands at $6.9 million.

Losers

  • Plus Therapeutics (NASDAQ:PSTV) shares fell 36.6% to $0.2 during Wednesday's regular session. The market value of their outstanding shares is at $1.1 million.
  • Eyenovia (NASDAQ:EYEN) stock fell 33.36% to $4.64. The company's market cap stands at $13.3 million.
  • Biomea Fusion (NASDAQ:BMEA) stock fell 33.11% to $1.94. The company's market cap stands at $70.3 million.
  • CERo Therapeutics Hldgs (NASDAQ:CERO) stock declined by 29.81% to $13.92. The market value of their outstanding shares is at $5.7 million.
  • Beyond Air (NASDAQ:XAIR) shares fell 23.13% to $0.22. The company's market cap stands at $19.3 million. As per the news, the Q4 earnings report came out yesterday.
  • Rafael Holdings (NYSE:RFL) stock declined by 22.12% to $1.51. The market value of their outstanding shares is at $53.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.